Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Bricanyl Turbuhaler M3 vs M2 in Asthma
NCT02322788Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of terbutaline in asthma (4 arms), sponsored by AstraZeneca. Primary endpoint: Provocative Concentration of Methacholine Causing a 20% Drop in FEV1. Started Mar 2015; status: completed.
02
Drugs
terbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02322788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322788.